Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medibio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 431.0K | 365.0K | 134.0K | 102.0K | 40.0K | 22.0K | ||
| Cost of goods sold | 76.0K | 226.0K | 205.0K | 171.0K | 1.0K | |||
| Gross profit | 2.4M | 3.9M | 721.0K | 1.1M | 1.0M | 960.0K | 889.0K | 1.1M |
| Gross profit margin, % | 553.4% | 1061.9% | 538.1% | 1073.5% | 2512.5% | 4363.6% | ||
| Operating expense total | 17.5M | 9.4M | 4.2M | 2.4M | 3.3M | 2.2M | 2.2M | 2.0M |
| Depreciation and amortization | 1.3M | 542.0K | 149.0K | 199.0K | 10.4M | 1.9M | 93.0K | 52.0K |
| EBITDA | (15.1M) | (5.5M) | (3.5M) | (1.3M) | (2.3M) | (1.2M) | (1.3M) | (866.0K) |
| EBITDA margin, % | -3503.9% | -1512.1% | -2606.0% | -1248.0% | -5720.0% | -5445.5% | ||
| EBIT | (16.4M) | (6.1M) | (3.6M) | (1.5M) | (12.7M) | (3.1M) | (1.4M) | (918.0K) |
| EBIT margin, % | -3812.3% | -1660.5% | -2717.2% | -1443.1% | -31772.5% | -13895.5% | ||
| Interest income | 139.0K | 30.0K | 8.0K | 1.0K | 2.0K | 4.0K | 9.0K | |
| Interest expense | 8.0K | 14.0K | 37.0K | 16.0K | 9.0K | 14.0K | 13.0K | 34.0K |
| Pre tax profit | (16.3M) | (6.6M) | (3.9M) | (1.5M) | (12.7M) | (3.1M) | (1.4M) | (943.0K) |
| Net Income | (16.3M) | (6.6M) | (3.9M) | (1.5M) | (12.7M) | (3.1M) | (1.4M) | (943.0K) |